Sun Pharmaceutical Industries Limited (SUNPHARMA.BO)
INR 1688.75
(1.22%)
INR 1688.75
(1.22%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 104.3 Billion INR | 14.49% |
| 2022 | 91.1 Billion INR | 12.12% |
| 2021 | 81.25 Billion INR | 25.03% |
| 2020 | 64.98 Billion INR | 24.04% |
| 2019 | 52.39 Billion INR | 6.45% |
| 2018 | 49.22 Billion INR | 19.76% |
| 2017 | 41.09 Billion INR | -51.58% |
| 2016 | 84.88 Billion INR | 12.97% |
| 2015 | 75.14 Billion INR | 7.95% |
| 2014 | 69.6 Billion INR | -2.23% |
| 2013 | 71.19 Billion INR | 44.25% |
| 2012 | 49.35 Billion INR | 45.59% |
| 2011 | 33.89 Billion INR | 60.49% |
| 2010 | 21.12 Billion INR | 49.29% |
| 2009 | 14.14 Billion INR | -27.41% |
| 2008 | 19.49 Billion INR | 21.87% |
| 2007 | 15.99 Billion INR | 91.9% |
| 2006 | 8.33 Billion INR | 39.63% |
| 2005 | 5.96 Billion INR | 41.82% |
| 2004 | 4.2 Billion INR | 10.41% |
| 2003 | 3.81 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 31.84 Billion INR | 6.06% |
| 2024 Q1 | 30.02 Billion INR | 23.01% |
| 2023 Q1 | 26.78 Billion INR | 24.13% |
| 2023 Q4 | 24.41 Billion INR | -10.58% |
| 2023 Q3 | 27.3 Billion INR | 5.79% |
| 2023 Q2 | 25.8 Billion INR | -3.65% |
| 2023 FY | 104.3 Billion INR | 14.49% |
| 2022 Q1 | 21.5 Billion INR | 32.52% |
| 2022 Q4 | 21.57 Billion INR | -8.06% |
| 2022 FY | 91.1 Billion INR | 12.12% |
| 2022 Q2 | 25.88 Billion INR | 20.34% |
| 2022 Q3 | 23.46 Billion INR | -9.32% |
| 2021 Q4 | 16.22 Billion INR | -21.34% |
| 2021 FY | 81.25 Billion INR | 25.03% |
| 2021 Q1 | 22.37 Billion INR | 67.89% |
| 2021 Q3 | 20.63 Billion INR | -5.18% |
| 2021 Q2 | 21.75 Billion INR | -2.77% |
| 2020 Q1 | 15.01 Billion INR | 92.54% |
| 2020 Q2 | 19.5 Billion INR | 29.91% |
| 2020 Q3 | 21.89 Billion INR | 12.24% |
| 2020 Q4 | 13.33 Billion INR | -39.11% |
| 2020 FY | 64.98 Billion INR | 24.04% |
| 2019 Q2 | 15.17 Billion INR | -13.37% |
| 2019 Q1 | 17.51 Billion INR | 148.39% |
| 2019 Q3 | 14.14 Billion INR | -6.79% |
| 2019 Q4 | 7.79 Billion INR | -44.86% |
| 2019 FY | 52.39 Billion INR | 6.45% |
| 2018 Q2 | 14.55 Billion INR | 3.63% |
| 2018 FY | 49.22 Billion INR | 19.76% |
| 2018 Q1 | 14.04 Billion INR | -8.24% |
| 2018 Q4 | 7.05 Billion INR | -62.39% |
| 2018 Q3 | 18.74 Billion INR | 28.78% |
| 2017 Q3 | 12.43 Billion INR | -2.24% |
| 2017 Q2 | 12.71 Billion INR | 41.15% |
| 2017 FY | 41.09 Billion INR | -51.58% |
| 2017 Q1 | 9.01 Billion INR | -37.16% |
| 2017 Q4 | 15.31 Billion INR | 23.14% |
| 2016 Q3 | 22.68 Billion INR | -23.96% |
| 2016 Q1 | 27.62 Billion INR | 26.13% |
| 2016 Q4 | 14.33 Billion INR | -36.79% |
| 2016 Q2 | 29.83 Billion INR | 8.01% |
| 2016 FY | 84.88 Billion INR | 12.97% |
| 2015 FY | 75.14 Billion INR | 7.95% |
| 2015 Q1 | 16.91 Billion INR | 133.17% |
| 2015 Q4 | 21.89 Billion INR | 1.03% |
| 2015 Q3 | 21.67 Billion INR | 25.32% |
| 2015 Q2 | 17.29 Billion INR | 2.25% |
| 2014 Q4 | 7.25 Billion INR | -60.98% |
| 2014 Q3 | 18.59 Billion INR | -32.77% |
| 2014 FY | 69.6 Billion INR | -2.23% |
| 2014 Q1 | 18.84 Billion INR | 9.72% |
| 2014 Q2 | 27.66 Billion INR | 46.78% |
| 2013 Q1 | 15.28 Billion INR | 19.27% |
| 2013 FY | 71.19 Billion INR | 44.25% |
| 2013 Q4 | 17.17 Billion INR | -15.4% |
| 2013 Q3 | 20.3 Billion INR | 9.9% |
| 2013 Q2 | 18.47 Billion INR | 20.89% |
| 2012 Q3 | 11.76 Billion INR | -6.73% |
| 2012 Q2 | 12.61 Billion INR | 11.16% |
| 2012 Q1 | 11.34 Billion INR | 3.29% |
| 2012 FY | 49.35 Billion INR | 45.59% |
| 2012 Q4 | 12.81 Billion INR | 8.89% |
| 2011 Q4 | 10.98 Billion INR | 23.96% |
| 2011 Q3 | 8.86 Billion INR | 5.38% |
| 2011 FY | 33.89 Billion INR | 60.49% |
| 2011 Q2 | 8.41 Billion INR | 41.79% |
| 2011 Q1 | 5.93 Billion INR | 0.0% |
| 2010 FY | 21.12 Billion INR | 49.29% |
| 2009 FY | 14.14 Billion INR | -27.41% |
| 2008 FY | 19.49 Billion INR | 21.87% |
| 2007 FY | 15.99 Billion INR | 91.9% |
| 2006 FY | 8.33 Billion INR | 39.63% |
| 2005 FY | 5.96 Billion INR | 41.82% |
| 2004 FY | 4.2 Billion INR | 10.41% |
| 2003 FY | 3.81 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -1711.429% |
| Aurobindo Pharma Limited | 42.2 Billion INR | -147.148% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -1061.618% |
| Granules India Limited | 6.81 Billion INR | -1430.121% |
| Indoco Remedies Limited | 1.29 Billion INR | -7969.628% |
| Achyut Healthcare Limited | 4.43 Million INR | -2350145.606% |
| Ajanta Pharma Limited | 19.67 Billion INR | -430.072% |
| Alkem Laboratories Limited | 19.46 Billion INR | -435.939% |
| Alpa Laboratories Limited | 184.49 Million INR | -56434.198% |
| Brooks Laboratories Limited | 14.44 Million INR | -722226.177% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | -5973.007% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -8373.096% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | -54.002% |
| Eris Lifesciences Limited | 5.18 Billion INR | -1912.92% |
| FDC Limited | 2.98 Billion INR | -3392.852% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -1504.088% |
| Gufic Biosciences Limited | 1.32 Billion INR | -7742.929% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | -2259.523% |
| Ipca Laboratories Limited | 7.98 Billion INR | -1206.968% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -20427.011% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 68740.405% |
| Lasa Supergenerics Limited | -458 Million INR | 22873.529% |
| Laurus Labs Limited | 3.94 Billion INR | -2541.541% |
| Lupin Limited | 28.04 Billion INR | -271.923% |
| Mankind Pharma Limited | 21.51 Billion INR | -384.728% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Medico Remedies Limited | 100.3 Million INR | -103891.924% |
| Megasoft Limited | -121.1 Million INR | 86227.543% |
| NATCO Pharma Limited | 25.96 Billion INR | -301.756% |
| Piramal Pharma Limited | 4.55 Billion INR | -2188.922% |
| RPG Life Sciences Limited | 2.29 Billion INR | -4450.185% |
| Sigachi Industries Limited | 1.47 Billion INR | -6976.748% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -2163.715% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -41746.933% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Wanbury Limited | 569.71 Million INR | -18208.052% |
| Windlas Biotech Limited | 1.29 Billion INR | -7930.234% |
| ZIM Laboratories Limited | 253.82 Million INR | -40992.192% |
| Zydus Lifesciences Limited | 43.1 Billion INR | -141.965% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 2634.699% |
| Divi's Laboratories Limited | 33.08 Billion INR | -215.308% |
| Hester Biosciences Limited | 364.81 Million INR | -28491.294% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -3643.859% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -22696.474% |
| Bal Pharma Limited | 233.9 Million INR | -44491.657% |
| Strides Pharma Science Limited | 5.22 Billion INR | -1895.937% |
| Venus Remedies Limited | 534.65 Million INR | -19408.782% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -3234.4% |
| Nectar Lifesciences Limited | 923.8 Million INR | -11190.671% |
| Shilpa Medicare Limited | 1.36 Billion INR | -7534.197% |
| Aarti Drugs Limited | 7.14 Billion INR | -1359.057% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | -6432.058% |
| Suven Life Sciences Limited | -1.22 Billion INR | 8608.894% |
| Ind-Swift Limited | 1.22 Billion INR | -8407.909% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | -630.276% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 2807.153% |
| Themis Medicare Limited | 392.58 Million INR | -26468.218% |
| Hikal Limited | 32.11 Million INR | -324733.074% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | -311.696% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -16548.667% |
| Wockhardt Limited | -670 Million INR | 15667.746% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -1910.096% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -1150052.723% |
| Neuland Laboratories Limited | 5.31 Billion INR | -1861.303% |
| Morepen Laboratories Limited | 4.17 Billion INR | -2398.997% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -50034.054% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -379767.07% |